Kevin Laliberte serves as Executive at Dova Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Laliberte has executed 8 insider transactions totaling $309.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 12, 2019 involved selling 4,761 shares valued at $0.
Kevin Laliberte currently holds 5,357 shares of Dova Pharmaceuticals, Inc. (DOVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Laliberte has been a net seller of DOVA stock. They have purchased $105.4K and sold $204.5K worth of shares.
Kevin Laliberte's most recent insider trade was on Nov 12, 2019, when they sold 4,761 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $28.00 |
| Discretionary |
| Sep 30, 2019 | DOVA | $16.7K | Sale | 596 | $28.00 | Discretionary |
| Sep 25, 2019 | DOVA | $62.0K | Sale | 3,100 | $20.00 | Discretionary |
| Jul 31, 2019 | DOVA | $22.2K | Sale | 1,389 | $15.97 | Discretionary |
| Jul 1, 2019 | DOVA | $16.9K | Sale | 1,191 | $14.17 | Discretionary |
| Jan 4, 2019 | DOVA | $0 | Award | 7,937 | $N/A | Discretionary |
| Jul 5, 2017 | DOVA | $105.4K | Purchase | 6,200 | $17.00 | Discretionary |